Endpoints News39m
Oph­thal­mol­o­gy start­up Char­ac­ter Bio­sciences gets $93M for ge­net­ics-based ap­proach
Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines ...